Echo-If-AF: Echocardiographic Markers of Atrial Fibrillation Recurrence Post Radiofrequency Ablation

Sponsor
Centro Hospitalar e Universitário de Coimbra, E.P.E. (Other)
Overall Status
Recruiting
CT.gov ID
NCT05690529
Collaborator
(none)
100
1
26.1
3.8

Study Details

Study Description

Brief Summary

Determine echocardiographic predictors of atrial fibrillation recurrence post radiofrequency Ablation and evaluate markers of low voltage areas on 3D mapping.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ablation

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Echocardiographic Markers of Atrial Fibrillation Recurrence Post Radiofrequency Ablation
Actual Study Start Date :
Mar 29, 2022
Anticipated Primary Completion Date :
May 31, 2024
Anticipated Study Completion Date :
May 31, 2024

Arms and Interventions

Arm Intervention/Treatment
No recurrence

No recurrence of AF

Procedure: Ablation
Radiofrequency AF ablatoon

Recurrence

Recurrence of AF

Procedure: Ablation
Radiofrequency AF ablatoon

Outcome Measures

Primary Outcome Measures

  1. Recurrence [1 year]

Secondary Outcome Measures

  1. Low voltage areas [At procedure]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • paroxysmal or persistent ablation
Exclusion Criteria:
  • previous AF ablation

  • previous left atrial ablation

  • refusal to give informed consent

  • congenital cradiomiopathy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centro Hospitalar e Universitário de Coimbra Coimbra Portugal

Sponsors and Collaborators

  • Centro Hospitalar e Universitário de Coimbra, E.P.E.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Diogo de Almeida Fernandes, Dr., Centro Hospitalar e Universitário de Coimbra, E.P.E.
ClinicalTrials.gov Identifier:
NCT05690529
Other Study ID Numbers:
  • Echo AF 2021
First Posted:
Jan 19, 2023
Last Update Posted:
Jan 19, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Diogo de Almeida Fernandes, Dr., Centro Hospitalar e Universitário de Coimbra, E.P.E.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 19, 2023